Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets
19th August 2025, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from...
Tag : Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Tretinoin Cream
18th August 2025, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from...
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Carbamazepine Extended-Release Tablets.
28 July, 2025, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval...
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Amlodipine and Atorvastatin Tablets
23rd May, 2025, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the...
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg, and 20 mg
15 May, 2025 Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from...
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Ivabradine Tablets, 5 mg and 7.5 mg
12th November 2024, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) announced that it has received Final Approval from the...
Alembic honoured with Guinness World Record for Hypertension Awareness Milestone
~Over 15,000 Healthcare professionals take a pledge towards better hypertension management~ 12 November 2024, Bengaluru:...
Alembic Pharmaceuticals announces early participation in the Prime Minister’s Internship Scheme
7 October, 2024, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced its early participation in the Prime...
Alembic Pharmaceuticals announces USFDA Final Approval for Lamotrigine Extended-Release Tablets USP, 200 mg, 250 mg, and 300 mg.
3rd October 2024, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from...
Alembic Pharmaceuticals Limited received an Establishment Inspection Report (EIR) for its Oral Solid Formulation Facility(F-1) at Panelav.
30 September 2024, Bengaluru: Alembic Pharmaceuticals Limited is pleased to announce that it has received the...